Tanarra Capital
Tanarra Capital Pty Ltd is a Melbourne-based investment and advisory firm that focuses on venture capital and private equity. Established in 2005, it invests in a diverse array of early-stage ventures, private companies, and public entities, primarily in Australia and New Zealand. The firm has a particular interest in the business-to-business and healthcare sectors. Its portfolio includes notable companies such as Pexip, a leading video technology firm, and Genomics, which leverages genetic analysis to enhance pharmaceutical research and development. Tanarra also has a history of past investments, including Business Spectator, a business media publication that was acquired by News Corporation. With additional offices in Sydney, Perth, Auckland, and Hong Kong, Tanarra Capital aims to support innovative companies and contribute to their growth.
OXECO
Venture Round in 2022
OXECO is a chemistry technology firm specializing in the creation and manufacture of specialty chemicals for the clean technology and transportation industries. The company employs advanced carbene technology through its innovative ONTOTM platform, which allows for precise control over surface behavior. OXECO provides a range of surface treatment chemicals, including practical surface treatments, chemical insertions, and coatings that are both hydrophobic and hydrophilic. This enables clients to effectively modify and enhance the performance of surfaces in various applications.
Health Metrics
Acquisition in 2021
Health Metrics is a prominent provider of software solutions tailored for the aged care sector. The company develops comprehensive software designed for residential aged care, home care, and independent living units. Its platform features a clinical and administrative system that includes tools for customer relationship management (CRM), Medicare online claiming, clinical care, electronic rostering, electronic contracts, quality management, medication management, and virtual telehealth integration. These solutions enable clients to manage their clinics effectively and enhance operational efficiency.
August Robotics
Series A in 2020
August Robotics specializes in developing application-specific robots aimed at automating labor-intensive workflows within the B2B sector. The company has introduced its first two robots: Lionel, which streamlines the floor-marking process for the global exhibition industry, and Diego, which focuses on disinfecting high-traffic public spaces like hotels and offices to enhance hygiene and minimize infection risks. By leveraging its proprietary mobile robotics platform, August Robotics can rapidly create new robot models tailored to various tasks. The company's mission is to transform the physical workplace by optimizing efficiency, reliability, and safety in collaboration with human workers, ultimately improving business workflows across diverse industries.
Fraction
Seed Round in 2020
Fraction is a technology company that provides a fractional ownership infrastructure on an internet-scale. Users can invest in, sell, and manage fractional ownership of anything using its plug-and-play platform. Its products enable fractional ownership for real estate developers, small and medium-sized businesses, investment funds and pooled capital, and everything in between.
Inx Software
Acquisition in 2019
INX Software Pty Ltd, based in Perth, Australia, specializes in integrated workforce management software that addresses various aspects of operational efficiency, including safety, logistics, compliance, risk management, training, and occupational health. The company's solutions are designed to streamline processes and enhance compliance while minimizing risks. With a robust platform that supports over 500,000 users across more than 23 countries, INX Software offers services such as cloud hosting, predictive analytics, and implementation support. By centralizing data management, INX Software enables organizations to foster safe and sustainable workplaces.
Genomics PLC, established in 2014 and headquartered in Oxford, UK, specializes in developing algorithms and software solutions that harness the power of genomics. The company focuses on cancer, microbes, and rare diseases, offering solutions that transform healthcare provisions for governments and providers, de-risk drug development for pharmaceutical clients, enhance diagnoses and treatment options for clinicians, and ensure accurate result processing for research labs and genome analysts. By applying advanced analytics to massive genomic and phenotypic datasets, Genomics PLC aims to lead the genomic transformation of healthcare, revealing the human wiring diagram and setting standards for genomic data utilization.
Animal Dynamics
Series A in 2018
Animal Dynamics is a company focused on developing advanced robotics inspired by the principles of evolutionary biomechanics. By leveraging recent advancements in analytical technology, the company evaluates high-performance animals to understand the mechanisms behind their efficiency and effectiveness. Animal Dynamics integrates fine engineering with a deep comprehension of these natural designs to create innovative robotic systems. Their platform combines insights from nature with cutting-edge materials science, microelectronics, and software engineering, resulting in a new generation of robotic vehicles. These vehicles have applications in various sectors, including agriculture for crop spraying and surveying, as well as in humanitarian aid, fire suppression, and military logistics. The company's mission emphasizes not only performance beyond current engineering capabilities but also a commitment to environmental protection through inspiration drawn from nature.
Genomics PLC, established in 2014 and headquartered in Oxford, UK, specializes in developing algorithms and software solutions that harness the power of genomics. The company focuses on cancer, microbes, and rare diseases, offering solutions that transform healthcare provisions for governments and providers, de-risk drug development for pharmaceutical clients, enhance diagnoses and treatment options for clinicians, and ensure accurate result processing for research labs and genome analysts. By applying advanced analytics to massive genomic and phenotypic datasets, Genomics PLC aims to lead the genomic transformation of healthcare, revealing the human wiring diagram and setting standards for genomic data utilization.
August Robotics
Seed Round in 2018
August Robotics specializes in developing application-specific robots aimed at automating labor-intensive workflows within the B2B sector. The company has introduced its first two robots: Lionel, which streamlines the floor-marking process for the global exhibition industry, and Diego, which focuses on disinfecting high-traffic public spaces like hotels and offices to enhance hygiene and minimize infection risks. By leveraging its proprietary mobile robotics platform, August Robotics can rapidly create new robot models tailored to various tasks. The company's mission is to transform the physical workplace by optimizing efficiency, reliability, and safety in collaboration with human workers, ultimately improving business workflows across diverse industries.
Arctoris
Pre Seed Round in 2018
Arctoris Limited is a biotechnology company based in Oxford, United Kingdom, with additional operations in Boston and Singapore. Founded in 2016, Arctoris has developed a unique automated drug discovery platform that combines advanced robotics and data science to enhance the efficiency of drug discovery programs. The platform enables researchers and biotech entrepreneurs to design and execute cellular and molecular biology experiments online, generating high-quality data from various biochemical and cell-based assays. By providing secure data storage, analysis, and visualization, Arctoris allows clients to make informed decisions with reliable and well-annotated data. The company's approach focuses on oncology and neurodegenerative diseases, actively pursuing drug discovery programs while also offering access to its platform for select partners in the biotech and pharmaceutical sectors. This data-driven strategy aims to increase the likelihood of success and accelerate the progression of new therapies toward clinical application.
Ultromics
Series A in 2018
Ultromics Limited, founded in 2017 and based in Oxford, United Kingdom, specializes in developing advanced echocardiography software aimed at enhancing the diagnosis of coronary heart disease. The company leverages artificial intelligence to create diagnostic tools that significantly improve the accuracy of echocardiography, with reported enhancements exceeding 90%. Ultromics' technology focuses on analyzing complex data from electrocardiograms, enabling healthcare providers to make informed decisions in diagnosing coronary artery disease. By providing innovative solutions for cardiologists, Ultromics aims to transform cardiovascular diagnostics and improve patient outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.